290 related articles for article (PubMed ID: 38396408)
21. Diabetic macular oedema: pathophysiology, management challenges and treatment resistance.
Bahrami B; Zhu M; Hong T; Chang A
Diabetologia; 2016 Aug; 59(8):1594-608. PubMed ID: 27179659
[TBL] [Abstract][Full Text] [Related]
22. VEGF-targeting drugs for the treatment of retinal neovascularization in diabetic retinopathy.
Arrigo A; Aragona E; Bandello F
Ann Med; 2022 Dec; 54(1):1089-1111. PubMed ID: 35451900
[TBL] [Abstract][Full Text] [Related]
23. Emerging drugs for the treatment of diabetic retinopathy.
Striglia E; Caccioppo A; Castellino N; Reibaldi M; Porta M
Expert Opin Emerg Drugs; 2020 Sep; 25(3):261-271. PubMed ID: 32715794
[TBL] [Abstract][Full Text] [Related]
24. American Society of Retina Specialists Clinical Practice Guidelines on the Management of Nonproliferative and Proliferative Diabetic Retinopathy without Diabetic Macular Edema.
Yonekawa Y; Modi YS; Kim LA; Skondra D; Kim JE; Wykoff CC
J Vitreoretin Dis; 2020 Mar; 4(2):125-135. PubMed ID: 34308094
[TBL] [Abstract][Full Text] [Related]
25. Maternal immune system adaptation to pregnancy--a potential influence on the course of diabetic retinopathy.
Kaštelan S; Tomić M; Pavan J; Orešković S
Reprod Biol Endocrinol; 2010 Oct; 8():124. PubMed ID: 20964838
[TBL] [Abstract][Full Text] [Related]
26. Management of preeclampsia.
Dekker GA
Pregnancy Hypertens; 2014 Jul; 4(3):246-7. PubMed ID: 26104648
[TBL] [Abstract][Full Text] [Related]
27. Pan-retinal photocoagulation and other forms of laser treatment and drug therapies for non-proliferative diabetic retinopathy: systematic review and economic evaluation.
Royle P; Mistry H; Auguste P; Shyangdan D; Freeman K; Lois N; Waugh N
Health Technol Assess; 2015 Jul; 19(51):v-xxviii, 1-247. PubMed ID: 26173799
[TBL] [Abstract][Full Text] [Related]
28. Obstetric nephrology: pregnancy in women with diabetic nephropathy--the role of antihypertensive treatment.
Mathiesen ER; Ringholm L; Feldt-Rasmussen B; Clausen P; Damm P
Clin J Am Soc Nephrol; 2012 Dec; 7(12):2081-8. PubMed ID: 22917698
[TBL] [Abstract][Full Text] [Related]
29. Report of the Committee on the classification and diagnostic criteria of diabetes mellitus.
Kuzuya T; Nakagawa S; Satoh J; Kanazawa Y; Iwamoto Y; Kobayashi M; Nanjo K; Sasaki A; Seino Y; Ito C; Shima K; Nonaka K; Kadowaki T;
Diabetes Res Clin Pract; 2002 Jan; 55(1):65-85. PubMed ID: 11755481
[TBL] [Abstract][Full Text] [Related]
30. A Caveat About Financial Incentives for Anti-Vascular Endothelial Growth Factor Therapy for Diabetic Retinopathy.
Young BK; Hwang M; Johnson MW; Besirli CG; Wubben TJ
Am J Ophthalmol; 2022 Nov; 243():77-82. PubMed ID: 35901996
[TBL] [Abstract][Full Text] [Related]
31. Anti-VEGF crunch syndrome in proliferative diabetic retinopathy: A review.
Tan Y; Fukutomi A; Sun MT; Durkin S; Gilhotra J; Chan WO
Surv Ophthalmol; 2021; 66(6):926-932. PubMed ID: 33705807
[TBL] [Abstract][Full Text] [Related]
32. Update on current pharmacologic therapies for diabetic retinopathy.
Muns SM; Villegas VM; Flynn HW; Schwartz SG
Expert Opin Pharmacother; 2023; 24(14):1577-1593. PubMed ID: 37431888
[TBL] [Abstract][Full Text] [Related]
33. Biologic Therapy and Treatment Options in Diabetic Retinopathy with Diabetic Macular Edema.
Nissen TPH; Vorum H; Aasbjerg K
Curr Drug Saf; 2021; 16(1):17-31. PubMed ID: 32881673
[TBL] [Abstract][Full Text] [Related]
34. Diabetic retinopathy and diabetic macular oedema pathways and management: UK Consensus Working Group.
Amoaku WM; Ghanchi F; Bailey C; Banerjee S; Banerjee S; Downey L; Gale R; Hamilton R; Khunti K; Posner E; Quhill F; Robinson S; Setty R; Sim D; Varma D; Mehta H
Eye (Lond); 2020 Jun; 34(Suppl 1):1-51. PubMed ID: 32504038
[TBL] [Abstract][Full Text] [Related]
35. Planned birth at or near term for improving health outcomes for pregnant women with gestational diabetes and their infants.
Biesty LM; Egan AM; Dunne F; Dempsey E; Meskell P; Smith V; Ni Bhuinneain GM; Devane D
Cochrane Database Syst Rev; 2018 Jan; 1(1):CD012910. PubMed ID: 29303230
[TBL] [Abstract][Full Text] [Related]
36. Prevalence, progression, and outcomes of diabetic retinopathy during pregnancy in Indian scenario.
Makwana T; Takkar B; Venkatesh P; Sharma JB; Gupta Y; Chawla R; Vohra R; Kriplani A; Tandon N
Indian J Ophthalmol; 2018 Apr; 66(4):541-546. PubMed ID: 29582816
[TBL] [Abstract][Full Text] [Related]
37. Prognostic factors for the development and progression of proliferative diabetic retinopathy in people with diabetic retinopathy.
Perais J; Agarwal R; Evans JR; Loveman E; Colquitt JL; Owens D; Hogg RE; Lawrenson JG; Takwoingi Y; Lois N
Cochrane Database Syst Rev; 2023 Feb; 2(2):CD013775. PubMed ID: 36815723
[TBL] [Abstract][Full Text] [Related]
38. Current Approaches in Treatment of Diabetic Retinopathy and Future Perspectives.
Kutlutürk Karagöz I; Allahverdiyev A; Bağırova M; Abamor EŞ; Dinparvar S
J Ocul Pharmacol Ther; 2020 Sep; 36(7):487-496. PubMed ID: 32453671
[TBL] [Abstract][Full Text] [Related]
39. Oral anti-diabetic agents for women with pre-existing diabetes mellitus/impaired glucose tolerance or previous gestational diabetes mellitus.
Tieu J; Coat S; Hague W; Middleton P
Cochrane Database Syst Rev; 2010 Oct; (10):CD007724. PubMed ID: 20927764
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
